Nexalin Technology, Inc. (NXL)
NASDAQ: NXL · Real-Time Price · USD
4.270
-0.630 (-12.86%)
At close: Sep 21, 2026, 4:00 PM EDT
4.410
+0.140 (3.28%)
Pre-market: Sep 22, 2026, 8:14 AM EDT
Nexalin Technology Market Cap
Nexalin Technology has a market cap or net worth of $3.14 million as of September 21, 2026. Its market cap has decreased by -80.74% in one year.
Market Cap
3.14M
Enterprise Value
2.13M
1-Year Change
-80.74%
Ranking
Category
Stock Price
$4.27
ChartMarket Cap Chart
Since the IPO on September 16, 2022, Nexalin Technology's market cap has decreased from $16.38M to $3.14M, a decrease of -80.85%. That is a compound annual growth rate of -33.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 3.14M | -69.86% |
| Dec 31, 2025 | 10.41M | -70.68% |
| Dec 31, 2024 | 35.50M | 1,079.21% |
| Dec 29, 2023 | 3.01M | -44.79% |
| Dec 30, 2022 | 5.45M | -66.71% |
| Sep 16, 2022 | 16.38M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Phaos Technology Holdings (Cayman) Limited | 5.18M |
| INVO Fertility | 4.63M |
| WORK Medical Technology Group LTD | 4.62M |
| Aethlon Medical | 4.49M |
| Bluejay Diagnostics | 4.11M |
| Autonomix Medical | 4.09M |
| VolitionRx | 3.69M |
| Vivos Therapeutics | 3.28M |